COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
To improve care delivery, conserve personal protective equipment and limit the exposure to SARS-CoV-2, nurses at Montefiore Medical Center in New York City relocated smart IV infusion pumps outside of patient rooms
The Food and Drug Administration (FDA) warned people to stop using two tests produced by Empowered Diagnostics: CovClear COVID-19 Rapid Antigen Test
Changes to guidance from the Centers for Disease Control and Prevention (CDC) have left nurses who test positive for COVID-19 questioning how best to protect their patients.
A new page on the Food and Drug Administration (FDA) website explains how genetic mutations in the COIVID-19 virus may impact the accuracy of existing tests for SARS-CoV-2.
The Centers for Disease Control and Prevention (CDC) updated its list of high-risk conditions for
Operational planning information for pediatric COVID-19 vaccination is now available on the website
Last week, the Biden-Harris Administration announced $2.1 billion in American Rescue Plan funding will be used to improve infection prevention and control activities across
To address the unique challenges the COVID-19 pandemic produced for people with intellectual and developmental disabilities, the Centers for Disease Control and Prevention
The Centers for Disease Control and Prevention (CDC) released data this week affirming the safety of COVID-19 vaccines early in pregnancy.
Effective this month, the U.S. Food and Drug Administration (FDA) revoked emergency use authorizations (EUAs) for non-NIOSH-approved disposable respirators